The central executive authority shaping and implementing state policies in the field of healthcare shall publish on its official website the information on the international non-proprietary name, trade name, pharmaceutical form and dosage of the medication for which the Controlled Access Agreement has been concluded, as well as the information on the applicant's authorised representative (if any), the validity period of the Controlled Access Agreement.